- Current report filing (8-K)
August 10 2011 - 8:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
August 10, 2011
Adolor Corporation
(Exact name of registrant as specified in its charter)
Delaware
|
|
000-30039
|
|
31-1429198
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer
|
of incorporation)
|
|
|
|
Identification No.)
|
700 Pennsylvania Drive, Exton, PA
|
|
19341
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(484) 595-1500
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01
Other Events
.
On August 10, 2011, Adolor Corporation (the Company) issued a press release announcing top line results from its Phase 2 studies of ADL5945 in chronic non-cancer pain patients with opioid-induced constipation (OIC). A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference.
Item 9.01
Financial Statements and Exhibits
.
(d)
Exhibits
.
Exhibit No.
|
|
Description of Document
|
99.1
|
|
Press release dated August 10, 2011
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
ADOLOR CORPORATION
|
|
|
|
|
|
|
|
By
|
/s/ John M. Limongelli
|
|
Name:
|
John M. Limongelli
|
|
Title:
|
Sr. Vice President, General Counsel and Secretary
|
|
|
|
|
|
|
Dated: August 10, 2011
|
|
|
3
EXHIBIT INDEX
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press Release dated August 10, 2011
|
4
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024